Malaria associated pathogenesis of chronic kidney disease (MAP-CKD)

疟疾相关的慢性肾病发病机制(MAP-CKD)

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Acute kidney injury (AKI) is an abrupt loss of kidney function that occurs in 25-59% of children hospitalized with severe malaria. AKI is one of the strongest risk factors for death in children with severe malaria and is associated with long-term cognitive and kidney problems. Following injury, the kidney undergoes a repair process to restore normal kidney function. If the repair process goes awry and is ‘maladaptive’, it can lead to persistent kidney injury and chronic kidney disease (CKD). Our previous studies showed an increased risk of CKD in severe malaria survivors. These results led to our central hypothesis that persistent activation of pathways associated with severe malaria associated-AKI contributes to maladaptive repair following AKI and increases CKD risk. Towards this hypothesis, we have preliminary data showing that persistent immune activation and signs of altered blood vessel function are associated with persistent kidney disease at one-month follow-up. An estimated 15.6% of Ugandan children have persistent kidney injury after severe malaria with 17.5% of children with persistent kidney injury dying within one-year follow-up compared to 3.7% without AKI. Guided by strong preliminary data, we propose a prospective multi-site observational cohort study to follow 750 Ugandan children, 90 days to 15 years of age, hospitalized with severe malaria to assess the incidence of CKD. We will also enroll 189 community children of the same age to define the incidence of CKD in Ugandan children. We will pursue two Specific Aims to evaluate the malaria-associated pathogenesis of acute and chronic kidney disease (MAP-CKD) after severe malaria. In Aim 1, we will determine clinical risk factors associated with CKD, including the severity and duration of AKI as well as a poorly understood complication of malaria called blackwater fever. We will also evaluate the genetic risk factors for CKD in children over follow-up, focusing on genes linked to kidney disease (e.g., APOL1) or protection from severe malaria (e.g., sickle cell anemia). In Aim 2, we will focus on defining mechanisms of maladaptive repair following AKI by measuring biomarkers in children’s blood and urine over follow-up. These studies will have the potential to uncover pathways of maladaptive repair following AKI that lead to the development of CKD and are amenable to intervention. Our long-term goal is to prevent children from developing CKD. These studies will achieve this goal by allowing us to identify children at the highest risk of CKD, providing clinical follow-up and early treatment for CKD. Secondly, by determining the maladaptive nature of the healing process, we will be able to use biomarkers to identify children at risk of CKD. Third, these studies have the potential to identify treatments to promote adaptive renal repair and reduce CKD development. Collectively, our proposed research will provide new insights into kidney disease in malaria and may provide novel insights into mechanisms of maladaptive repair in other conditions characterized by intravascular hemolysis and AKI. The results from this study will help define the burden of CKD following AKI in low-and-middle-income countries, where 80% of global AKI deaths occur.
项目概要/摘要 急性肾损伤 (AKI) 是一种肾功能突然丧失的情况,25-59% 的住院儿童会发生这种情况 严重的疟疾。 AKI 是严重疟疾儿童死亡的最强危险因素之一,并且与 患有长期认知和肾脏问题。受伤后,肾脏会经历修复过程以恢复 肾功能正常。如果修复过程出错并且“适应不良”,可能会导致持续性肾损伤 和慢性肾脏病(CKD)。我们之前的研究表明严重疟疾患 CKD 的风险增加 幸存者。这些结果引出了我们的中心假设,即与相关通路的持续激活 严重疟疾相关 AKI 会导致 AKI 后的适应不良修复,并增加 CKD 风险。向 根据这个假设,我们有初步数据表明,持续的免疫激活和血液改变的迹象 在一个月的随访中,血管功能与持续性肾脏疾病相关。估计有15.6% 乌干达儿童患严重疟疾后出现持续性肾损伤,17.5%的儿童患有持续性肾损伤 受伤后一年内死亡,而没有 AKI 的死亡人数为 3.7%。在强有力的初步数据的指导下,我们 提出一项前瞻性多中心观察队列研究,对 750 名乌干达儿童进行为期 90 天至 15 岁的跟踪研究 年龄,因严重疟疾住院以评估 CKD 的发病率。我们还将报名189社区 同龄儿童来定义乌干达儿童 CKD 的发病率。我们将追求两个具体目标 评估重症后与疟疾相关的急性和慢性肾脏病 (MAP-CKD) 的发病机制 疟疾。在目标 1 中,我们将确定与 CKD 相关的临床危险因素,包括严重程度和持续时间 AKI 以及一种人们知之甚少的疟疾并发症——黑水热。我们还将评估 随访中儿童 CKD 的遗传风险因素,重点关注与肾脏疾病相关的基因(例如 APOL1) 或预防严重疟疾(例如镰状细胞性贫血)。在目标 2 中,我们将重点关注定义机制 通过在随访过程中测量儿童血液和尿液中的生物标志物来修复 AKI 后的适应不良。这些 研究将有可能揭示 AKI 后适应不良修复的途径,从而导致 CKD 的发展并且适合干预。我们的长期目标是防止儿童发育 慢性肾病。这些研究将通过让我们识别 CKD 风险最高的儿童来实现这一目标,并提供 CKD 的临床随访和早期治疗。其次,通过确定治疗的适应不良性质 在此过程中,我们将能够使用生物标志物来识别有慢性肾病风险的儿童。第三,这些研究有 确定促进适应性肾脏修复和减少 CKD 发展的治疗方法的潜力。总的来说,我们的 拟议的研究将为疟疾中的肾脏疾病提供新的见解,并可能为以下方面提供新的见解: 其他以血管内溶血和 AKI 为特征的疾病中适应不良修复的机制。这 这项研究的结果将有助于确定中低收入国家 AKI 后 CKD 的负担, 全球 80% 的 AKI 死亡发生在此处。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrea L. Conroy其他文献

The kidney–brain pathogenic axis in severe falciparum malaria
严重恶性疟的肾-脑致病轴
  • DOI:
    10.1016/j.pt.2023.01.005
  • 发表时间:
    2023-03-01
  • 期刊:
  • 影响因子:
    6.600
  • 作者:
    Andrea L. Conroy;Dibyadyuti Datta;Angelika Hoffmann;Samuel C. Wassmer
  • 通讯作者:
    Samuel C. Wassmer
Elevated uric acid levels, mortality and cognitive impairment in children with severe malaria
严重疟疾儿童的血尿酸水平升高、死亡率和认知障碍
  • DOI:
    10.1038/s41591-024-03430-8
  • 发表时间:
    2025-01-24
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Caitlin Bond;Olivia J. Bednarski;Dibyadyuti Datta;Ruth Namazzi;Robert O. Opoka;Giselle Lima-Cooper;Anthony Batte;Keerthi Udumula;Deepali Balasubramani;Marilyn Vasquez;Ana Rodriguez;Claire Liepmann;Paul Bangirana;Marco Abreu;Tae-Hwi Schwantes-An;Yi Zhao;Tarek M. El-Achkar;Nathan W. Schmidt;Chandy C. John;Andrea L. Conroy
  • 通讯作者:
    Andrea L. Conroy
Hydroxyurea Pharmacokinetics and Fetal Hemoglobin Response in Ugandan Children with Sickle Cell Anemia
  • DOI:
    10.1182/blood-2022-170839
  • 发表时间:
    2022-11-15
  • 期刊:
  • 影响因子:
  • 作者:
    Alexandra Power-Hays;Min Dong;Kathryn McElhinney;Andrea L. Conroy;Teresa Latham;Adam Lane;Robert O. Opoka;Alexander A. Vinks;Russell E. Ware
  • 通讯作者:
    Russell E. Ware
Soluble T cell immunoglobulin and mucin-domain containing protein 3 in children hospitalized with pneumonia in resource-limited settings
  • DOI:
    10.1016/j.cyto.2022.155794
  • 发表时间:
    2022-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Usman Ahmed;Jeremy Soo;Andrea L. Conroy;Sophie Namasopo;Robert O. Opoka;Ravi Bhargava;Michael T. Hawkes
  • 通讯作者:
    Michael T. Hawkes
Severe falciparum malaria in young children is associated with an increased risk of post-discharge hospitalization: a prospective cohort study
  • DOI:
    10.1186/s12936-024-05196-3
  • 发表时间:
    2024-12-04
  • 期刊:
  • 影响因子:
    3.000
  • 作者:
    Robert O. Opoka;Ruth Namazzi;Dibyadyuti Datta;Paul Bangirana;Andrea L. Conroy;Michael J. Goings;Kagan A. Mellencamp;Chandy C. John
  • 通讯作者:
    Chandy C. John

Andrea L. Conroy的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrea L. Conroy', 18)}}的其他基金

Malaria associated pathogenesis of chronic kidney disease (MAP-CKD)
疟疾相关的慢性肾病发病机制(MAP-CKD)
  • 批准号:
    10522245
  • 财政年份:
    2022
  • 资助金额:
    $ 58.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了